BRIEF-ARCA Biopharma announces randomization of first European patients in genetic-AF phase 2b/3 clinical trial
Oct 6 ARCA Biopharma Inc :
* Arca Biopharma announces randomization of first European patients in genetic-AF phase 2b/3 clinical trial
* Company expects to randomize at least 150 patients into trial by end of 2016
* Company expects outcome of interim analysis in q2 of 2017
* Genetic-Af DSMB to conduct nterim efficacy, safety,futility analysis of data from at least 150 patients with evaluable data Source text for Eikon: Further company coverage:
AT&T reaches deal to buy Time Warner for more than $80 billion -WSJ
Oct 22 AT&T Inc reached a deal to buy media company Time Warner Inc for more than $80 billion, The Wall Street Journal reported on Saturday.
Trump vows to weaken U.S. media 'power structure' if elected
GETTSYBURG, Pa. , Oct 22 U.S. Republican presidential candidate Donald Trump promised on Saturday to foil a proposed deal for AT&T Inc to buy Time Warner Inc if he wins the Nov. 8 election, arguing it was an example of a "power structure" rigged against both him and voters.